We further find a strong and highly significant association between a higher cost-sharing and PPE growth, suggesting that a 1% increase in private pharmaceutical expenditure growth reduces PPE growth by roughly 0.3%.
← all excerpts
Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms : Cross-country evidence from weighted-average least squares estimation.
1
—
—